(0.80%) 5 168.86 points
(0.26%) 38 776 points
(0.93%) 16 306 points
(0.56%) $78.55
(2.43%) $2.19
(1.11%) $2 334.20
(3.65%) $27.66
(-0.04%) $964.95
(-0.01%) $0.929
(-0.38%) $10.83
(-0.10%) $0.796
(-0.12%) $91.35
Quarter results today
(bmo 2024-05-06)
Expected move: +/- 11.34%
1.34% $ 75.81
@ $74.81
Emitido: 6 may 2024 @ 10:40
Retorno: 1.33%
Señal anterior: may 3 - 15:47
Señal anterior:
Retorno: -0.55 %
Live Chart Being Loaded With Signals
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States...
Stats | |
---|---|
Volumen de hoy | 685 428 |
Volumen promedio | 723 995 |
Capitalización de mercado | 3.59B |
EPS | $0 ( 2024-02-20 ) |
Próxima fecha de ganancias | ( $-1.200 ) 2024-06-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -14.38 |
ATR14 | $4.67 (6.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Jacobson Mark L. | Buy | 24 662 | Common Stock |
2024-04-01 | Jacobson Mark L. | Sell | 24 662 | Stock Option (Right to Buy) |
2024-04-01 | Jacobson Mark L. | Sell | 24 662 | Common Stock |
2024-03-14 | Jeffs Roger | Buy | 16 976 | Common Stock |
2024-03-14 | Jeffs Roger | Buy | 13 000 | Common Stock |
INSIDER POWER |
---|
55.25 |
Last 99 transactions |
Buy: 2 269 939 | Sell: 680 650 |
Volumen Correlación
Axsome Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
MMAC | 0.888 |
AMGN | 0.885 |
BOCH | 0.879 |
PDCO | 0.878 |
MIRM | 0.876 |
RNEM | 0.87 |
BATRA | 0.869 |
SINO | 0.866 |
BATRK | 0.86 |
VIRI | 0.858 |
10 Correlaciones Más Negativas | |
---|---|
APOP | -0.937 |
TDAC | -0.893 |
MAGS | -0.891 |
CMLF | -0.868 |
BHTG | -0.861 |
VTRU | -0.848 |
GAINL | -0.847 |
TRIT | -0.845 |
RMRM | -0.843 |
XOG | -0.842 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Axsome Therapeutics Inc Correlación - Moneda/Commodity
Axsome Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $270.60M |
Beneficio Bruto: | $237.70M (87.84 %) |
EPS: | $-5.27 |
FY | 2023 |
Ingresos: | $270.60M |
Beneficio Bruto: | $237.70M (87.84 %) |
EPS: | $-5.27 |
FY | 2022 |
Ingresos: | $50.04M |
Beneficio Bruto: | $44.84M (89.61 %) |
EPS: | $-4.86 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-3.47 |
Financial Reports:
No articles found.
Axsome Therapeutics Inc
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico